Hydroxyurea decreases painful events among children with sickle cell disease (SCD) but could increase the risk of infections in treated patients through leucopenia. We performed a case-control study, comparing hydroxyurea treatment for SCD in cases with an invasive bacterial infection and in controls without infection. No difference was found.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jpids/piae071 | DOI Listing |
Publication Analysis
Top Keywords
sickle cell
8
cell disease
8
invasive bacterial
8
case-control study
8
hydroxyurea sickle
4
disease invasive
4
bacterial infections
4
infections case-control
4
study hydroxyurea
4
hydroxyurea decreases
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!